Détail du congrès:
Congrès: Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) (9-13 mai 2005)
Commentaire :
AFM
Auteur(s) ayant un renvoi vers celui-ci :
|
Documents disponibles provenant de ce congrès (412)
trié(s) par (Date de parution décroissant(e), Date de parution décroissant(e), Système de projection du document croissant(e)) | Mettre toutes les notices dans le panier | Faire une suggestion | Ajouter un critère de recherche
Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Alameddine HS ; Morgan J ; Bausero P ; Gross J | 2005Communication n° 377 A soluble and membrane-bound metallo-endopeptidase activity has been shown to be involved in myoblast fusion (Couch and Stritmatter 1983, and 1984). Furthermore, MMP-2 and MMP-9 activation and regulation during skeletal musc[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Lunardi J ; Monnier N ; Kozak-Ribbens G ; Krivosic-Horber R ; Nivoche Y ; Payen JF ; Figarella-Branger D ; Mezin P ; Romero NB ; Maclennan D | 2005Communication n° 335 Malignant hyperthermia susceptibility (MHS) is a sub clinical pharmacogenetic disorder caused by an impairment of skeletal muscle calcium homeostasis in response to triggering agents. MHS involve two calcium channels located[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Eliat PA ; Nguyen F ; Pinot M ; Franconi F ; Lemaire L ; Cherel Y | 2005Communication n° 287. Introduction : Magnetic resonance imaging (MRI) has been used to study in vivo anatomy and water content of dystrophin-deficient skeletal muscle in the murine model (mdx) of Duchenne Muscular Dystrophy. Data are however lac[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Jouvion G ; Rouger K ; Fornasari B ; Bougras G ; Goubault-Leroux I ; Primault R ; Segalen J | 2005Communication n° 297. The ability of skeletal muscle to repair and regenerate itself after injury has been ascribed to satellite cells (SC), a subpopulation of undifferentiated mononuclear cells that reside in the tissue. However, other progenit[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Feferman T ; Cizeron-Clairac G ; Fuchs S ; Souroujon M ; Berrih-Aknin S | 2005Communication n° 448 Myasthenia Gravis (MG) is an autoimmune disease mediated by antibodies directed against the acetylcholine receptor (AChR), which are found in about 85% of patients. Autoimmune experimental MG (EAMG) can be induced in rats by[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Charland L ; Lavoie J ; Puymirat J | 2005Communication n° 119 Use of databases (DB) for managing neuromuscular diseases (NMD) data is an impressive tool for physicians and researchers. We have developed a DB on an Oracle platform. Oracle has a solid architecture witch is only limited b[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; 't Hoen PAC ; Sterrenburg E ; van der Wees C ; White S ; Turk R ; de Menezes R ; van Ommen G ; den Dunnen J | 2005Communication n° 439. Duchenne Muscular Dystrophy (DMD) is a lethal disease characterized by progressive muscle weakness and wasting. Despite the sustained presence of satellite cells in their skeletal muscles, muscle regeneration is inefficient[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Morel JL ; Rakotoarisoa I ; Mironneau J | 2005Communication n° 135. It is generally believed that alterations of calcium homeostasis play a key role in skeletal muscle atrophy and degeneration observed in Duchenne's muscular dystrophy and mdx mice. Mechanical activity is also impaired in ga[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Colomer J ; Müller JS ; Nascimiento A ; Vernet A ; Lochmuller H | 2005Communication n° 188 Introduction: The majority of postsynaptic congenital myasthenic syndromes (CMS) result from deficiency of acetylcholine receptors (AChR) at the endplate, due to mutations of the gene encoding the epsilon subunit of the AChR[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Girard C ; Neel H ; Bertrand E ; Bordonne R | 2005Communication n° 654 Neuronal degeneration in spinal muscular atrophy (SMA) is caused by reduced expression of the survival of motor neuron (SMN) protein. The SMN protein is ubiquitously expressed and is present both in the cytoplasm and in the [...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Orcesi S ; Rossi M ; Gorni K ; Berardinelli A ; Beghi E ; Angelini C ; Bertini E ; Pini A ; Palmucci L ; Mercuri E ; Lanzi G | 2005Communication n° 196 Introduction : One of the major goals both in the general management of Neuromuscular Disorders (NMDs) and in therapeutic trials is increasingly recognized as the improvement or at least prevention of worsening of heath-rela[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Solly S ; Herson S ; Klatzmann D ; Benveniste O | 2005Communication n° 725. Introduction : Polymyositis (PM) is characterised by a proximal muscle weakness and a muscular infiltrate made by macrophages and cytotoxic CD8+ T lymphocytes. Without treatment mortality is up to 70 percent. The basis of t[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; El Fahime E ; Benabdallah BF ; Tremblay J | 2005Communication n° 169 Therapies are currently investigating the use of the newly identified pluripotent muscle derived stem cells (MDSCs), as a possible cell-mediated therapy, in order to repopulate the dystrophic muscles. The existence of MDSCs,[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Martin N ; Dutertre M ; Auboeuf D | 2005Communication n° 688. Introduction : Important efforts are currently done to identify mutations associated with genetic neuromuscular diseases. Classically, most of the interest is focused in the coding regions of the genes, even if we know that[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Hackman P ; Pelin K ; Monni O ; Auvinen P ; Udd B | 2005Communication n° 468. Introduction : Tibial muscular dystrophy TMD/LGMD2J is caused by mutations in the TTN gene. Due to its huge size (363 exons encoding 38,138 amino acid residues), the search for new mutations can be a very laborious task usi[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Routledge S ; Sterrenburg E ; van der Maarel SM ; Antoniou M | 2005Communication n° 491 INTRODUCTION : Oculopharyngeal muscular dystrophy (OPMD) is an autosomal dominant, late-onset disease caused by the expansion of an alanine (ala) tract at the N terminus of the nuclear poly(A)-binding protein (PABPN1) from 1[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Rolland JF ; Burdi R ; Giannuzzi V ; Liantonio A ; Conte Camerino D ; de Luca A | 2005Communication n° 162. Introduction : The mechanisms underlying the high sarcolemmal permeability to Ca2+ and the perturbed Ca2+ homeostasis in muscle fibers of dystrophic mdx mouse are still debated. Objective. To perform a biophysical and pharm[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Ben Sassi S ; Amouri R ; Kefi M ; Hentati F | 2005Communication n° 535 Inter- and intrafamilial phenotypic heterogeneity has been reported in LGMD2C and in sarcoglycanopathies in general. This clinical variability has been related to modifying gene(s) or to environmental factors. We report a pa[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Duval C ; Camara Y ; Villarroya F | 2005Communication n° 428. Skeletal muscle can undergo apoptosis as a post-mitotic tissue both in response to specific physiological stimuli or in pathological processes. Acquisition of an apoptosis-resistant status is part of differentiation program[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Nancy P ; Berrih-Aknin S | 2005Communication n° 505 Myasthenia gravis (MG) is an autoimmune disease associated with thymic hyperplasia, and is much more prevalent in women than in men. In this study we investigated potential changes in estrogen receptor (ER) expression in thy[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Olaso R ; Joshi V ; Fernandez J ; Bonnefont JP ; Roblot N ; Courageot S ; Melki J | 2005Communication n° 254 Spinal Muscular Atrophy (SMA) is a frequent autosomal recessive neuromuscular disorder characterized by degeneration of motor neurons and caused by mutations of the SMN gene. SMN is thought to be involved in RNA metabolism. [...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Frenkian-Cuvelier M ; Boneva N ; Clairac G ; Bidault J ; Berrih-Aknin S | 2005Communication n° 512 The Aquired Autoimmune Myasthenia Gravis (MG) is characterized by 3 immunological entities : seropositive MG (SPMG), seronegative MG (SNMG) and MuSK+. Despite the different immunological profile, all MG patients present the [...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Charvet C ; Sotiropoulos A ; Houbron C ; Parlakian A ; Bertrand A ; Lahoute C ; Schmidt A ; Renou L ; Melki J ; Paulin D ; Li Z ; Daegelen D ; Tuil D | 2005Communication n° 497. SRF is a transcriptional factor involved in both cell growth and muscle-specific gene expression. Our previous data obtained in cultured muscle cells showed that SRF is needed for myoblasts differentiation. Classical disrup[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Marston S ; Messer A ; Mirza M ; Watkins H ; Redwood C ; Robinson P | 2005Communication n° 245 In failing heart muscle there is a defect in contractility due to dysfunction of the contractile apparatus. In previous studies we identified a specific functional defect in the thin filament regulatory protein troponin extr[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Fleurance R ; Rouger K ; Guigand L ; Le Rumeur E ; Cherel Y | 2005Communication n° 295. In the membrane of healthy animals, dystrophin is associated with a complex named dystrophin-glycoprotein complex. This complex seems to be absent in dystrophin-deficient animals or humans Aim : Assess the consequences of d[...]